WORLDWIDE FIRST FINALIZED STUDY OF PRECLINICAL LIFE-SUPPORTING ORTHOTOPIC PIG-TO-BABOON CARDIAC XENOTRANSPLANTATION (XT): CONSTANT REPRODUCIBLE 3-MONTHS-SURVIVAL UP TO HALF A YEAR MEETS THE ISHLT GUIDELINES FOR FIRST CLINICAL TRIALS
暂无分享,去创建一个
E. Wolf | S. Buchholz | K. Reimann | B. Reichart | D. Ayares | N. Klymiuk | C. Hagl | S. Steen | P. Brenner | W. Hermanns | J. Abicht | T. Mayr | M. Längin | S. Guethoff | S. Michel | M. Mokelke | J. Radan | A. Bauer | F. Werner | I. Lutzmann | Lara Issl | Jiawei Ying | Ann Kathrin Fresch | I. Buttgereit
[1] R. F. Hoyt,et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft , 2016, Nature Communications.